These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4053482)

  • 21. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era.
    Lee CT; Tung YC; Hsiao PH; Lee JS; Tsai WY
    J Formos Med Assoc; 2010 Feb; 109(2):148-55. PubMed ID: 20206839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical analysis of 52 cases of 21-hydroxylase-deficient congenital adrenal hyperplasia].
    Yang Y; Zhou XY; Zhou XG
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):613-7. PubMed ID: 26108325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenocortical tumor in a patient with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Pang S; Becker D; Cotelingam J; Foley TP; Drash AL
    Pediatrics; 1981 Aug; 68(2):242-6. PubMed ID: 6267548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Children with classic congenital adrenal hyperplasia experience salt loss and hypoglycemia: evaluation of adrenal crises during the first 6 years of life.
    Odenwald B; Nennstiel-Ratzel U; Dörr HG; Schmidt H; Wildner M; Bonfig W
    Eur J Endocrinol; 2016 Feb; 174(2):177-86. PubMed ID: 26563979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenal tumors associated with inadequately treated congenital adrenal hyperplasia.
    Wang J; Bissada MA; Williamson HO; Yakout H; Bissada NK
    Can J Urol; 2002 Jun; 9(3):1563-4. PubMed ID: 12121582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Over 50 years of progress in the treatment of the hypertensive form of congenital adrenal hyperplasia due to steroid 11-beta-hydroxylase deficiency. Commentary on Simm PJ and Zacharin MR: Successful pregnancy in a patient with severe 11-beta-hydroxylase deficiency and novel mutations in CYP11B1 gene (Horm Res 2007;68:294-297).
    Migeon CJ
    Horm Res; 2007; 68(6):298-9. PubMed ID: 17726334
    [No Abstract]   [Full Text] [Related]  

  • 27. Prolonged hypertension following cessation of desoxycorticosterone therapy in congenital adrenal hyperplasia.
    Marks JF; Fink CW
    Pediatrics; 1967 Aug; 40(2):184-7. PubMed ID: 5006581
    [No Abstract]   [Full Text] [Related]  

  • 28. Salt-wasting 21-hydroxylase deficiency congenital adrenal hyperplasia and pyloric stenosis in two Hispanic brothers.
    Pitukcheewanont P; Nimkarn S; Austin J; Sack Z; Fisher LK
    J Pediatr; 2006 Aug; 149(2):268-70. PubMed ID: 16887450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of breast feeding on the clinical features of salt-losing congenital adrenal hyperplasia.
    Curtis JA; Bailey JD
    Arch Dis Child; 1983 Jan; 58(1):71-3. PubMed ID: 6830279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pubertal delay, hypokalemia, and hypertension caused by a rare form of congenital adrenal hyperplasia.
    Olson CA; Crudo DF
    J Pediatr Adolesc Gynecol; 2011 Apr; 24(2):e29-31. PubMed ID: 21190871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of adult men with congenital adrenal hyperplasia syndrome due to 21-hydroxylase deficiency].
    Knape P; Reisch N; Dörr HG; Reincke M; Quinkler M
    Dtsch Med Wochenschr; 2008 May; 133(19):1025-9. PubMed ID: 18446680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal concentrating ability in dehydrated hyponatremic dogs.
    Tyler RD; Qualls CW; Heald RD; Cowell RL; Clinkenbeard KD
    J Am Vet Med Assoc; 1987 Nov; 191(9):1095-100. PubMed ID: 3693027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Images in clinical medicine. Congenital adrenal hyperplasia.
    Ko PJ; Yeh ML
    N Engl J Med; 2015 Jun; 372(24):e32. PubMed ID: 26061858
    [No Abstract]   [Full Text] [Related]  

  • 34. Acanthosis nigricans in association with congenital adrenal hyperplasia: resolution after treatment. Case report.
    Kurtoğlu S; Atabek ME; Keskin M; Canöz O
    Turk J Pediatr; 2005; 47(2):183-7. PubMed ID: 16052863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Congenital adrenal hyperplasia].
    Yanase T; Haji M; Nawata H
    Nihon Rinsho; 1992 May; 50 Suppl():686-92. PubMed ID: 1513014
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acute complications during treatment of virilizing congenital adrenal hyperplasia deficiency due to 21-hydroxylase].
    Job JC; Canlorbe P; Lambertz J; Courouble P; Rossier A
    Ann Pediatr (Paris); 1970; 17(6):426-31. PubMed ID: 5421325
    [No Abstract]   [Full Text] [Related]  

  • 37. [Aggravation of salt loss due to hydrocortisone in the first days of treatment of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency].
    Bey-Omar F; Feit JP; Forest MG; David M
    Pediatrie; 1983 Mar; 38(2):77-86. PubMed ID: 6622141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Congenital adrenal hyperplasia causing hypertension].
    Yanase T
    Nihon Naika Gakkai Zasshi; 2006 Apr; 95(4):657-61. PubMed ID: 16722432
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of hyponatremic encephalopathy with a 3% sodium chloride protocol: a case series.
    Ayus JC; Caputo D; Bazerque F; Heguilen R; Gonzalez CD; Moritz ML
    Am J Kidney Dis; 2015 Mar; 65(3):435-42. PubMed ID: 25465163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart failure secondary to latrogenic systemic hypertension in an infant with congenital adrenal hyperplasia.
    Geggel RL; DeLuca K; Villee DB
    Clin Pediatr (Phila); 1984 Jun; 23(6):358-60. PubMed ID: 6723181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.